Karnataka woos US investors in pharma & biotechnology sectors to invest in KWIN City

Karnataka is actively seeking to attract investments from US-based life sciences companies to boost its pharmaceutical and biotechnology sectors. The state government is showcasing its robust infrastructure, skilled workforce, and favorable business environment to invest in its Knowledge, Wellbeing, and Innovation (KWIN) City.
Initiatives like networking to seek partnerships with research institutions, and incentives for foreign companies to set up operations in Karnataka are aimed to position the state as a global hub for life sciences.
During his recent visit to the US, Karnataka Minister for Large and Medium Industries M B Patil held discussions with representatives from GE Healthcare, L3 Harris Technologies, and Johns Hopkins University, focusing on future collaborations and growth opportunities.
The KWIN City spanning 2,000 acres between Doddaspete and Doddaballapur, approximately 60 kilometers from Bengaluru, is at strategic location along the Satellite Town Ring Road (STRR) to foster collaboration among academic institutions, industry leaders, and research organizations. It includes state-of-the-art facilities, research labs, and educational institutions, promoting research and skilled workforce training.
In the US, the Karnataka delegation met the senior leadership from Johns Hopkins University, including representatives from the Carey Business School, Bloomberg School of Public Health and the School of Medicine. These discussions focused on potential opportunities for collaboration between the US institution and Karnataka’s academic ecosystem. Of particular interest was the establishment of a higher education institution in Karnataka’s newly launched KWIN City, he said.
The minister expressed hope to make Karnataka a global leader in research, healthcare and higher education and called on Johns Hopkins University to play a pivotal role in this transformation. The state is playing host to the Invest Karnataka Summit 2025, where presence of leading US lifesciences companies is expected to further catalyze high-tech investment and innovation in the region.
Discussions with Andrew Quinn, executive director of International Trade and Policy at GE Healthcare was also explored to strengthen the potential synergies in the medical devices sector. The dialogue centered on enhancing the ecosystem for medical device manufacturing in Karnataka, leveraging the state’s robust infrastructure and talent pool.
Source: pharmabiz